Skip to content
🧪 Theranos

People in the Theranos case — founders, reporter, judge, partners

Six figures who structure the Theranos public record: Holmes, Balwani, Carreyrou, Judge Davila, a Walgreens counterpart, and a laboratory director.

The Theranos docket names investors, scientists, and retail executives. The six below are the ones the trials and the 2015 investigation keep in frame.

Roles are taken from verdicts, the SEC complaint, CMS files, and the Journal’s contemporaneous reporting.

People

Elizabeth Holmes

Founder and CEO; defendant

Convicted in January 2022 of investor wire fraud and conspiracy. Sentenced in November 2022 to 135 months. Acquitted on patient-related wire-fraud counts.

Ramesh “Sunny” Balwani

President and COO; defendant

Romantic and business partner for years. Convicted in July 2022 on all counts tried, including patient-related fraud; sentenced to 155 months.

John Carreyrou

Wall Street Journal reporter

Author of the October 2015 investigation and the 2018 book Bad Blood. His sourcing from former employees opened the public enforcement path.

Edward J. Davila

U.S. District Judge

Northern District of California judge who presided over both criminal trials and imposed the 2022 sentences.

Jay Rosan

Walgreens executive counterpart

A Walgreens executive involved in the partnership that put collection sites in stores — the retail fact that made the technology claim testable.

Adam Rosendorff

Laboratory director (former)

A former lab director whose concerns about quality and the use of conventional analyzers became part of the Journal’s sourcing and later trial testimony.

Board names such as George Shultz and Henry Kissinger appear in the prestige story; they were not criminal defendants. David Boies’s legal campaign against early sources is part of the press history, not the verdict.

Public-record encyclopedia. Not legal advice. Not a how-to. Graphic detail is withheld. Wars belong in a separate atlas.

Related cases